Global Digital Respiratory Devices Market - Analysis and Forecast, 2019-2029

Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape

Published Year: 2019
SKU: BHM0717SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Market Overview

          1.1    Introduction
          1.2    Digital Respiratory Devices Market Ecosystem
          1.3    Assumptions and Limitations

2 Market Dynamics

          2.1    Impact Analysis
          2.2    Market Drivers
                   2.2.1    Increasing Prevalence of Respiratory Diseases
                   2.2.2    Increasing Adoption of Digital Technology Among Individuals
                   2.2.3    Treatment Satisfaction with Inhaled Therapy Among Individuals
          2.3    Market Restraints
                   2.3.1    Issues Related to The Accuracy and Reliability of the Device
                   2.3.2    Availability and High Cost Associated with Digital Respiratory Devices
          2.4    Market Opportunities
                   2.4.1    Expansion into the Emerging Markets
                   2.4.2    Predicting Future Exacerbations

3 Competitive Landscape

          3.1    Key Developments and Strategies
                   3.1.1    Agreements and Collaborations
                   3.1.2    Product Approvals
                   3.1.3    Mergers and Acquisitions
                   3.1.4    Awards and Recognitions
                   3.1.5    Investments, Funding, and Business Expansion
                   3.1.6    Product Launches
          3.2    Market Share Analysis
          3.3    Industry Attractiveness
                   3.3.1    Bargaining Power of Suppliers
                   3.3.2    Bargaining Power of Buyer
                   3.3.3    Threat of New Entrants
                   3.3.4    Threat of Substitute Products
                   3.3.5    Intensity of Competitive Rivalry

4 Industry Insights

          4.1    Opportunity Map Analysis of Smart Inhalers and Nebulizers
          4.2    Smart Inhaler Value Propositions for Stakeholders
          4.3    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
          4.4    Business Models for Digital Respiratory Devices Market

5 Global Digital Respiratory Devices Market (by Product Type)

          5.1    Sensors and Apps
          5.2    Smart Inhalers and Nebulizers

6 Global Digital Respiratory Devices Market (by Indication)

          6.1    Asthma
          6.2    Chronic Obstructive Pulmonary Disease (COPD)

7 Global Digital Respiratory Devices Market (by Region)

          7.1    North America
                   7.1.1    U.S.
                   7.1.2    Canada
          7.2    Europe
                   7.2.1    Germany
                   7.2.2    U.K.
                   7.2.3    France
                   7.2.4    Rest-of-Europe
          7.3    Asia-Pacific (APAC)
                   7.3.1    Japan
                   7.3.2    China
                   7.3.3    Australia
                   7.3.4    India
                   7.3.5    Rest-of-Asia-Pacific (RoAPAC)
                   7.3.6    Rest-of-the-World (RoW)

8 Company Profiles

          8.1    3M Health Care Limited
                   8.1.1    Company Overview
                   8.1.2    Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market.
                   8.1.3    Financials
                               8.1.3.1    Key Insights on the Financial Health of the Company
                   8.1.4    SWOT Analysis
          8.2    Adherium Limited
                   8.2.1    Company Overview
                   8.2.2    Role of Adherium Limited in the Global Digital Respiratory Devices Market.
                   8.2.3    Financials
                               8.2.3.1    Key Insights on the Financial Health of the Company
                   8.2.4    SWOT Analysis
          8.3    Amiko Digital Health Limited
                   8.3.1    Company Overview
                   8.3.2    Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
                   8.3.3    SWOT Analysis
          8.4    AstraZeneca plc
                   8.4.1    Company Overview
                   8.4.2    Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
                   8.4.3    Financials
                               8.4.3.1    Key Insights on the Financial Health of the Company
                   8.4.4    SWOT Analysis
          8.5    Boehringer Ingelheim International GmbH
                   8.5.1    Company overview
                   8.5.2    Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
                   8.5.3    Financials
                               8.5.3.1    Key Insights on the Financial Health of the Company
                   8.5.4    SWOT Analysis
          8.6    Capsule Technologies, Inc.
                   8.6.1    Company Overview
                   8.6.2    Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
                   8.6.3    SWOT Analysis
          8.7    Cohero Health
                   8.7.1    Company Overview
                   8.7.2    Role of Cohero Health in the Global Digital Respiratory Devices Market
                   8.7.3    SWOT Analysis
          8.8    GlaxoSmithKline plc
                   8.8.1    Company overview
                   8.8.2    Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
                   8.8.3    Financials
                               8.8.3.1    Key Insights on the Financial Health of the Company
                   8.8.4    SWOT Analysis
          8.9    Novartis AG
                   8.9.1    Company overview
                   8.9.2    Role of Novartis AG in the Global Digital Respiratory Devices Market
                   8.9.3    Financials
                               8.9.3.1    Key Insights on the Financial Health of the Company
                   8.9.4    SWOT Analysis
         8.10   Propeller Health
                   8.10.1    Company Overview
                   8.10.2    Role of Propeller Health in the Global Digital Respiratory Devices Market
                   8.10.3    SWOT Analysis
         8.11   Sensiron AG
                   8.11.1    Company overview
                   8.11.2    Role of Sensiron AG in the Global Digital Respiratory Devices Market
                   8.11.3    Financials
                                 8.11.3.1    Key Insights on the Financial Health of the Company
                   8.11.4    SWOT Analysis
         8.12   Teva Pharmaceuticals Industries Ltd.
                   8.12.1    Company Overview
                   8.12.2    Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
                   8.12.3    Financials
                                 8.12.3.1    Key Insights on the Financial Health of the Company
                   8.12.4    SWOT Analysis

9 Research Scope and Methodology

          9.1    Product Definition
          9.2    Scope of the Research Study

List of Tables

Table 1: A Research and Facilitation Framework    
Table 2: Impact Analysis of Global Digital Respiratory Devices Market    
Table 2.1: Impact Analysis of Global Digital Respiratory Devices Market    
Table 2.2: Prevalence of Asthma in Key Countries, 2015-2017    
Table 2.3: Prevalence of COPD in Key Countries, 2015-2017    
Table 4.1: Smart Inhaler Value Propositions for Stakeholders    
Table 4.2: Different Data Revenue Streams    
Table 5.1: Smart Inhalers in Pipeline    
Table 6.1: Incidence of Asthma in Key Countries, 2015-2017    
Table 6.2: Incidence of COPD in Key Countries, 2015-2017

List of Figures

Figure 1:    Opportunities for Clinical Benefit
Figure 2:    Global Digital Respiratory Devices Market, 2018-2029
Figure 3:    Dominating Segments of Global Digital Respiratory Devices Market, 2018 and 2029
Figure 4:    Global Digital Respiratory Devices Market (by Product Type), 2018 and 2029
Figure 5:    Global Digital Respiratory Devices Market (by Indication), 2018 and 2029
Figure 6:    Global Digital Respiratory Devices Market (by Region), 2018 and 2029
Figure 7:    Strategies Incorporated to Expand the Global Reach
Figure 8:    Go-To-Market Strategy
Figure 1.1:    Digital Respiratory Devices Market Workflow
Figure 1.2:    Smart Inhalers and Data Flow
Figure 1.3:    Digital Respiratory Devices Market Ecosystem
Figure 3.1:    Competitive Landscape, January 2015 - May 2019
Figure 3.2:    Share of Key Developments and Strategies, January 2015- May 2019
Figure 3.3:    Agreements and Collaborations Share (by Companies), January 2015- May 2019
Figure 3.4:    Product Approvals Share (by Companies), January 2015- May 2019
Figure 3.5:    Mergers and Acquisitions Share (by Companies), January 2015- May 2019
Figure 3.6:    Awards and Recognitions Share (by Companies), January 2015- May 2019
Figure 3.7:    Investments, Fundings, and Business Expansions Share (by Companies), January 2015- May 2019
Figure 3.8:    Product Launches Share (by Companies), January 2015- May 2019
Figure 3.9:    Market Share Analysis, 2017 and 2018
Figure 3.10:    Porter’s Five Forces Analysis
Figure 3.11:    Bargaining Power of Suppliers: Overall Impact, 2018-2029
Figure 3.12:    Bargaining Power of Buyers: Overall Impact, 2018-2029
Figure 3.13:    Threat of New Entrant: Overall Impact, 2018-2029
Figure 3.14:    Threat of Substitute Products: Overall Impact, 2018-2029
Figure 3.15:    Intensity of Competitive Rivalry: Overall Impact, 2018-2029
Figure 4.1:    Opportunity Map Analysis of Digital Respiratory Devices Market
Figure 4.2:    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
Figure 5.1:    Global Digital Respiratory Devices Market (by Product Type)
Figure 5.2:    Global Digital Respiratory Devices Market Share (by Product Type), 2018 and 2029
Figure 5.3:    Global Digital Respiratory Devices Market (by Sensors and Apps), 2018-2029
Figure 5.4:    Global Digital Respiratory Devices Market (by Smart Inhalers and Nebulizers), 2018-2029
Figure 6.1:    Global Digital Respiratory Devices Market (by Indication)
Figure 6.2:    Global Digital Respiratory Devices Market Share (by Indication), 2018 and 2029
Figure 6.3:    Global Digital Respiratory Devices Market (by Asthma), 2018-2029
Figure 6.4:    Global Digital Respiratory Devices Market (by COPD), 2018-2029
Figure 7.1:    Global Digital Respiratory Devices Market (by Region)
Figure 7.2:    Global Digital Respiratory Devices Market (by Region), 2018-2029
Figure 7.3:    North America Digital Respiratory Devices Market, 2018-2029
Figure 7.4:    North America Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.5:    U.S. Digital Respiratory Devices Market, 2018-2029
Figure 7.6:    Canada Digital Respiratory Devices Market, 2018-2029
Figure 7.7:    Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.8:    Europe Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.9:    Germany Digital Respiratory Devices Market, 2018-2029
Figure 7.10:    U.K. Digital Respiratory Devices Market, 2018-2029
Figure 7.11:    France Digital Respiratory Devices Market, 2018-2029
Figure 7.12:    Rest-of-Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.13:    Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.14:    Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.15:    Japan Digital Respiratory Devices Market, 2018-2029
Figure 7.16:    China Digital Respiratory Devices Market, 2018-2029
Figure 7.17:    Australia Digital Respiratory Devices Market, 2018-2029
Figure 7.18:    India Digital Respiratory Devices Market, 2018-2029
Figure 7.19:    Rest-of-Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.20:    Rest-of-the-World Digital Respiratory Devices Market, 2018-2029
Figure 8.1:    Shares of Key Company Profiles
Figure 8.2:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.3:    Overall Financials, 2016-2018
Figure 8.4:    Net Revenue (by Business Segment), 2016-2018
Figure 8.5:    Net Revenue (by Region), 2016-2018
Figure 8.6:    R& D Expense, 2016-2018
Figure 8.7:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.8:    Overall Financials, 2016-2018
Figure 8.9:    R&D Expense, 2016-2018
Figure 8.10:    Amiko Digital Health Limited: Product Offerings
Figure 8.11:    AstraZeneca plc: Product Offerings
Figure 8.12:    AstraZeneca plc: Overall Financials, 2016-2018
Figure 8.13:    AstraZeneca plc: Net Revenue (by Region), 2016-2018
Figure 8.14:    AstraZeneca plc: R&D Expense, 2016-2018
Figure 8.15:    Boehringer Ingelheim International GmbH: Product Offerings
Figure 8.16:    Boehringer Ingelheim International GmbH: Overall Financials, 2016-2018
Figure 8.17:    Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2016-2018
Figure 8.18:    Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2016-2018
Figure 8.19:    Boehringer Ingelheim International GmbH: R& D Expense, 2016-2018
Figure 8.20:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.21:    GlaxoSmithKline plc: Product Offerings
Figure 8.22:    GlaxoSmithKline plc: Overall Financials, 2016-2018
Figure 8.23:    GlaxoSmithKline plc Net Revenue (by Business Segment), 2016-2018
Figure 8.24:    GlaxoSmithKline plc: Net Revenue (by Region), 2016-2018
Figure 8.25:    GlaxoSmithKline plc: R& D Expense, 2016-2018
Figure 8.26:    Novartis AG: Product Offerings
Figure 8.27:    Novartis AG: Overall Financials, 2016-2018
Figure 8.28:    Novartis AG Net Revenue (by Business Segment), 2016-2018
Figure 8.29:    Novartis AG: Net Revenue (by Region), 2016-2018
Figure 8.30:    Novartis AG: R& D Expense, 2016-2018
Figure 8.31:    Propeller Health: Product Offerings for Digital Respiratory Devices Market
Figure 8.32:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.33:    Overall Financials, 2017-2018
Figure 8.34:    Net Revenue (by Business Segment), 2017-2018
Figure 8.35:    Net Revenue (by Region), 2017-2018
Figure 8.36:    R&D Expense, 2016-2018
Figure 8.37:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.38:    Overall Financials, 2016-2018
Figure 8.39:    Net Revenue (by Business Segment), 2017-2018
Figure 8.40:    R&D Expense, 2016-2018
Figure 9.1:    Global Digital Respiratory Devices Market Segmentation
Figure 9.2:    Research Methodology
Figure 9.3:    Primary Research
Figure 9.4:    Secondary Research
Figure 9.5:    Data Triangulation
Figure 9.6:    Bottom-up Approach (Segment-wise Analysis)
Figure 9.7:    Top-down Approach (Segment-wise Analysis)
Figure 9.8:    Assumptions and Limitations
Figure 9.9:    Considered Factors for Data Prediction and Modeling

You may also like

Published Year: 2020

Global Precision Medicine Market: Focus on Ecosystem, Technology, Application, Country Data (21 Coun

The global precision medicine market is set to witness a CAGR of 11.13% during the period...

 

Global Digital Respiratory Devices Market - Analysis and Forecast, 2019-2029

Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape